Company / Operating Cash Flow per Share
Bone Biologics Corp Operating Cash Flow per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.11
FY2020
5-year range
-$0.77 / -$0.11
FY2017-FY2020
Trend
+31.7%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-0.77 to $-0.11 over the past 2 years.
Based on SEC 10-K filings.
-0.11 in FY2020.
Improved from $-0.77 to $-0.11 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, operating cash flow per share increased 31.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | -$0.11 | +31.7% |
| FY2019 | -$0.16 | +79.8% |
| FY2018 | -$0.77 | -556.0% |
| FY2017 | -$0.12 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026